Holen Sie sich die Stockscreener-App
10.15
2.31%
-0.24
Handel nachbörslich:
10.15
Kura Oncology Inc Aktie (KURA) Neueste Nachrichten
H.C. Wainwright Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $40 - Moomoo
Kura Oncology Reports 50% Response Rate in RCC Combination Study - Yahoo Finance
Kura Oncology reports up to 50% response rate for darlifarnib-cabozantinib combo in Phase 1a kidney cancer trial - Bitget
KURA Shows Promising Results in Phase 1a Kidney Cancer Trial - GuruFocus
Kura Oncology Reports Encouraging Phase 1a Data for Darlifarnib Plus Cabozantinib in Advanced Clear Cell Renal Cell Carcinoma - Quiver Quantitative
Kura's Drug Combo Shows 13-Month Median Without Progression - Stock Titan
Kura Oncology Inc (KURA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kura Oncology Inc (KURA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kura Oncology Inc (KURA) Institutional Confidence - TradingKey
Kura Oncology Inc (KURA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
Why Did KURA Stock Jump 13% In Pre-Market Today? - Stocktwits
Kura Oncology Inc (KURA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kura Oncology Inc (KURA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
KURA|Kura Oncology Inc|Price:10.499|Chg%:+0.109 - TradingKey
KURA|Kura Oncology Inc|Price:10.390|Chg%:-0.060 - TradingKey
KURA|Kura Oncology Inc|Price:10.690|Chg%:+0.300 - TradingKey
Enterprise value to EBIT forward of Kura Oncology, Inc. – NASDAQ:KURA - TradingView
Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a Promising 198% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Bank of America Securities Sticks to Their Buy Rating for Kura Oncology (KURA) - The Globe and Mail
(KURA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Barclays Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $28 - Moomoo
Is Kura Oncology (KURA) Undervalued On New FIT 001 Trial Data? - Yahoo Finance
Is Kura Oncology (KURA) Turning Darlifarnib Into a Foundational Precision Combo Platform? - Sahm
Enterprise value to revenue forward of Kura Oncology, Inc. – NASDAQ:KURA - TradingView
Kura Oncology presents new data supporting darl... - Pluang
Kura Oncology to Present First Long-Term Follow-Up Data - GlobeNewswire
Long-term kidney cancer data from Kura's drug due July 24 - Stock Titan
Enterprise value to EBITDA forward of Kura Oncology, Inc. – NASDAQ:KURA - TradingView
Price to earnings forward of Kura Oncology, Inc. – NASDAQ:KURA - TradingView
Price to sales forward of Kura Oncology, Inc. – NASDAQ:KURA - TradingView
Price to book forward of Kura Oncology, Inc. – NASDAQ:KURA - TradingView
Kura Oncology: A Menin Inhibitor Launch With More Than One Way To Win (NASDAQ:KURA) - Seeking Alpha
Kura Oncology (KURA) Jefferies London Healthcare Conference 2025 Summary - Quartr
Does Kura Oncology’s (KURA) Shift Into Russell Growth Indexes Redefine Its Core Investment Story? - Yahoo Finance
Kura Oncology outlines targeted cancer pipeline as investors watch clinical milestones - Ad-hoc-news.de
Kura Oncology (KURA) 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA summary - Quartr
Kura Oncology (KURA) Gains Nearly 3% as Shares Test Key Resistance ZoneAnalyst Downgrade Signals - dars.gov.et
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
KURA News | KURA ONCOLOGY INC (NASDAQ:KURA) - ChartMill
Kura Oncology Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Kura Oncology reports $5.8 million revenue in Q1 2026 - scanx.trade
Kura Oncology, Inc.(NasdaqGS:KURA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Kura Oncology, Inc.(NasdaqGS: KURA) added to Russell 2500 Growth Benchmark - marketscreener.com
Kura Oncology, Inc.(NasdaqGS: KURA) added to Russell 2000 Growth Benchmark - marketscreener.com
Kura Oncology, Inc.(NasdaqGS:KURA) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
Kura Oncology, Inc.(NasdaqGS: KURA) dropped from Russell 3000 Value Benchmark - marketscreener.com
Kura Oncology, Inc.(NasdaqGS: KURA) added to Russell 3000 Growth Benchmark - marketscreener.com
Kura Oncology, Inc. Actuals & Estimates (NASDAQ:KURA) - TradingView
Kura Oncology, Inc. Actuals & Estimates (HAM:KUR) - TradingView
Kura Oncology, Inc. liabilities 2021-2025 - Statista
Kura Oncology, Inc. Actuals & Estimates (DUS:KUR) - TradingView
KURA Forecast — Price Target — Prediction for 2027 - TradingView
Mizuho Securities Maintains Kura Oncology(KURA.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Insiders At Kura Oncology Sold US$1.5m In Stock, Alluding To Potential Weakness - 富途牛牛
Kura Oncology CMO Mollie Leoni sells $834,283 in common stock By Investing.com - Investing.com Australia
Form 4 Kura Oncology Inc For: 22 June - Investing.com India
Form 4 Kura Oncology Inc For: 22 June By Investing.com - Investing.com Nigeria
Kura Oncology CMO Mollie Leoni sells $834,283 in common stock - Investing.com
Kura Oncology (NASDAQ: KURA) CMO sells 84,929 shares in trading plan - Stock Titan
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):